Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iridium Catalyzed Allylic Substitution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103896816B details iridium-catalyzed synthesis offering high enantioselectivity and scalable production for pharmaceutical intermediates.
Patent CN102249969A discloses a high-regioselective iridium-catalyzed method for phenyl-(3-aryl-2-propenyl) selenides, offering cost reduction in pharmaceutical intermediate manufacturing.